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Abstract
Background: Catechol-O-Methyltransferase (COMT) plays a key role in dopamine and estrogen metabolism.
Recently, COMT haplotypes rather than the single polymorphism Val158Met have been reported to underlie
differences in protein expression by modulating mRNA secondary structure. So far, studies investigating the
epigenetic variability of the S-COMT (soluble COMT) promoter region mainly focused on phenotypical aspects, and
results have been controversial.
Methods: We assessed S-COMT promoter methylation in saliva and blood derived DNA with regard to early pre-
and postnatal growth as well as to genotype for polymorphisms rs6269, rs4633, and rs4680 (Val158Met) in 20
monozygotic twin pairs (mean age 4 years), who were discordant for intrauterine development due to severe feto-
fetal-transfusion syndrome. Methylation levels of two previously reported partially methylated cytosines were
determined by the quantitative SIRPH (SNuPE- IP RP HPLC) assay.
Results: Overall, we observed a high variability of S-COMT promoter methylation, which did not correlate with
individual differences in the pre- or postnatal growth pattern. Within the twin pairs however we noted a distinct
similarity that could be linked to underlying COMT genotypes. This association was subsequently confirmed in a
cohort of 93 unrelated adult controls. Interestingly, 158Val-alleles were found at both ends of the epigenotypical
range, which is in accordance with a recently proposed model of COMT haplotypes corresponding to a continuum
of phenotypical variability.
Conclusion: The strong heritable component of S-COMT promoter methylation found in our study needs to be
considered in future approaches that focus on interactions between COMT epigenotype and phenotype.
Background
Catechol-O-Methyltransferase (COMT) plays a key role in
dopamine and estrogen metabolism. In humans, the
COMT gene on chromosome 22q11.21 encodes two dif-
ferent protein isoforms, MB-COMT (membrane bound)
and S-COMT (soluble isoform), each with its own promo-
ter [1]. The influence of a functional SNP 158Met/Val
(rs4680), which is located within the coding region of both
MB-COMT and S-COMT, has been investigated in a
broad spectrum of psychiatric diseases and estrogen-
dependent disorders [2-4]. However, reported genotype
effects were often modest or even inconsistent, suggesting
the presence of additional functional SNPs within this
gene. Indeed, Diatchenko and co-workers identified three
common COMT haplotypes corresponding to a conti-
nuum of phenotypical variability, namely pain sensitivity,
with the 158Val allele being part of both the high- and
low-sensitive haplotype, whereas the haplotype containing
158Met associates with average pain sensitivity [5]. More
recently, the same group demonstrated that these three
haplotypes mediate their functional significance by altera-
tion of mRNA secondary structure such that the most
stable structure associates with the lowest protein level
and activity [6].
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which accumulate over lifetime are a second major deter-
minant of an individual’s gene expression pattern which
contributes to both physiological appearance and disease
disposition. The mechanisms behind this intra-generational
adaptation are complex and involve epigenetic processes
such as chromatin modification and DNA methylation
[7,8]. In mammals, DNA methylation occurs almost exclu-
sively at the cytosine of CG dinucleotides,a n ds e v e r a l
methods to quantify methylation at these elements have
been established in recent years [9,8-11]. Since then, first
studies analyzing COMT promoter methylation in relation
to phenotypical aspects have been published. Sasaki et al.
reported on MB-COMT promoter methylation in endome-
trial cancer but not in normal endometrial tissue; in
contrast, the S-COMT promoter was found to be unmethy-
lated in both cancerous and normal endometrium [12].
Partial methylation of the MB-COMT promoter was also
reported in human frontal lobe brain tissues, and hypo-
methylation at this area was observed in schizophrenia and
bipolar disorder patients [13]. Although no such clear asso-
ciation between methylation levels and disposition to schi-
zophrenia was found, Murphy et al. detected two CG sites
in the S-COMT promoter region with only partial methyla-
tion in both blood and brain tissues [14]. Subsequently,
Mill et al. analyzed methylation levels at these two CG sites
in a cohort of monozygotic twins with discordant birth
weight. Interestingly, the authors report on a considerable
variation in the concordance of methylation levels between
the twin pairs, which however did not associate with auxo-
logical variables at birth [15].
Since discordant birth weight in monozygotic twins can
arise from several pathologies, we decided to assess S-
COMT promoter methylation levels in a cohort of discor-
dant monozygotic twins that have been selected for severe
feto-fetal-transfusion syndrome (FFTS). This condition is
caused by anastomosing placental vessels that result in
unequal blood supply and thus substantial differences in
fetal nutrition between donor and recipient. In animal
models, the strategy of nutrient restriction is increasingly
used to investigate long-term epigenetic effects of intrau-
terine growth retardation [16-18]. In our cohort, we
observed a remarkable variation in S-COMT promoter
methylation levels in both blood and saliva derived DNA,
which did not correlate with pre- or postnatal growth
parameters. On the other hand, our data provide evidence
for a strong association of S-COMT promoter methylation
with the underlying COMT genotype.
Methods
Subjects
For an ongoing study that focuses on epigenetic para-
meters with respect to adverse intrauterine environment
we selected 20 Caucasian twin pairs with a discordant
intrauterine growth pattern due to severe feto-fetal
transfusion syndrome (FFTS). In all 20 pregnancies, this
condition had been diagnosed by mid-trimester ultra-
sound examinations, and endoscopic laser coagulation
of the anastomosing placental vessels was successfully
performed before 25 weeks of gestation in a single cen-
ter (Prof. Dr. K. Hecher, Barmbek Hospital, Hamburg,
Germany). Details on survival rates and early neonatal
outcome of this treatment regime are described else-
where [19]. All children were born in the local referring
hospital.
Mean age at birth was 34.8 weeks of gestation (SD ± 2.1
wks; range 29.7-37.4 wks). Mean birth weight of the entire
cohort was 1970 g (SD ± 500 g; range 790-3060 g). Birth
weight differences between donor and recipient ranged
from 0 to 62% (mean 20.5%). Since FFTS occurs exlusively
in monozygotic twin pregnancies, no further genetic
examinations were necessary to confirm their monozygos-
ity. 38 of 40 children of the present cohort did not suffer
from severe postnatal complications. Two children show a
significant delay of psychomotor development after major
intracranial bleeding shortly after birth; auxological and
epigenetic measurements of these two children were thus
interpreted with caution. On examination, mean age of
the cohort was 4.4 years (SD ± 0.6 yrs; range 2.7-5.1 yrs).
Auxological parameters including calculations of intra-
twin pair differences were expressed as SD-scores accord-
ing to national reference percentiles for singleton children
[20,21]. At any time, parameters between former donor
and recipient were classified as discordant if difference in
SD scores was 1.0 or higher (except for birth weight,
which is not normally distributed; birth weight discor-
dance was defined if difference was > 10%).
Unrelated control individuals (93 adult blood donors; 47
females) were recruited from the blood donation unit of
the Institute for Experimental Hematology and Transfu-
sion Medicine, University of Bonn. Written informed con-
sent was obtained from all participants or their parents.
The study was approved by the ethic’s committee of the
University of Bonn.
DNA samples and bisulfite conversion
DNA from blood lymphocytes was extracted using the
QiaAmp
® DNA purification kit (Qiagen, Germany). Buccal
cell derived DNA was collected and prepared from Ora-
gene
® saliva samples according to the manufacturer proto-
col (DNA Genotek, Canada). Suitable amounts of saliva
were obtained from 17 out of 20 twin pairs, while blood-
derived DNA was available from all 40 children. For methy-
lation analysis, a total of 1 μg DNA was modified by bisul-
fite conversion using the Epitect
® kit (Qiagen, Germany).
The basic principle of bisulfite modification is the chemical
conversion of unmethylated cytosine residues to uracil,
whereas methylated cytosines remain unchanged [22]. This
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specific cytosine methylation by several PCR-based down-
stream reactions [9,10,23].
Quantitative methylation analysis
Site-specific methylation was determined at two CG
dinucleotides within the S-COMT promoter region
(Figure 1) which have been found to be partially methy-
lated in two previous studies [14,15]. A detailed descrip-
tion of the SIRPH (SNuPE IP RPH P L C )a s s a yu s e di s
given elsewhere [23]. Briefly, a single nucleotide primer
extension reaction (SNuPE) of bisulfite converted DNA
in combination with ion pair reverse phase high perfor-
mance liquid chromatography (IP RP HPLC) enables dis-
crimination and quantification of methylated and
unmethylated CGs based on the respective mass and
hydrophobicity of the extended primer product. An
example demonstrating the chromatographic discrimina-
tion between methylated and unmethylated cytosines is
given in Figure 2. All measurements were done in dupli-
cate, including repeated DNA extraction and bisulfite
conversion. Variation between the two runs was thor-
oughly below 5%. Methylation levels given in the results
section represent the respective average values.
A potential amplification bias due to additional SNPs
that would cause mismatch of amplification and/or
extension primers was ruled out by genomic sequencing
of the surrounding regions in all 20 twin pairs. We did
not detect any further sequence variation in our DNA
samples. A screen of online databases revealed only one
SNP (rs72563160) within the primer complementary
regions. This variant is found with a low frequency
(0.04) in African populations and seems to be absent in
Caucasians http://www.ncbi.nlm.nih.gov/projects/SNP.
Oligonucleotide sequences for PCR and SNuPE reac-
tions are available on request.
Genotyping
Genotypes for the rs4680 variant (Val158Met) were ana-
lyzed by PCR-RFLP, using an NlaIII restriction digest as
described previously [24]. Genotypes for rs6269 (-91 bp
to ATG) and rs4633 (in twins only; +186 bp to ATG)
were determined by direct genomic sequencing. This
method was chosen primarily in order to exclude addi-
tional sequence variation within or bordering to the
amplified region.
Based on the genotype information for these three
SNPs, we constructed haplotypes to each individual.
According to the findings of Diatchenko and coworkers
Figure 1 Genomic sequence flanking the S-COMT promoter region (atg in italics). Primer sequences for the PCR amplification of bisulfite-
converted DNA are Ampl Fwd: 5’ TAGGAGGAGTATAGAGTATTG 3’ and Ampl Rev: 5’ TATCACCCATAAACAAATTATA 3’; Ext1 and Ext2 bordering
CG1 and CG2 indicate the complementary extension primer sequences used in the SNuPE analysis.
Figure 2 A SNuPE IP RP HPLC example showing the
discrimination of extension primer only vs. extended primer
oligonucleotides (T with higher molecular weight than C).
Methylation levels can be calculated by comparison of the relative
heights of Ext.+C (formerly methylated cytosine) and Ext.+T (formerly
unmethylated cytosine). Differences in length and composition of
the two extension primers allowed discrimination of two separate
extension primer sets (Ext.1 and Ext.2) within one SNuPE run.
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tion carry three major functional haplotypes which are
formed by four SNPs. We are aware that we have ana-
lyzed only three (rs6269-A/G, rs4633-C/T, rs4680-A/G)
of these four variants (lacking rs4818-C/G) in twins, and
only two (rs6269-A/G, rs4680-A/G) in blood donors.
However, determination of the latter two genotypes is
sufficient to differentiate between the three common
COMT activity haplotypes [25]. Assessment of individual
haplotypes in twins and blood donors was performed by
the FAMHAP software [26]. Haplotype frequencies in
both cohorts (twins: LPS 0.450, APS 0.525, HPS 0.025;
blood donors: LPS 0.385, APS 0.516, HPS 0.093) were
comparable to those reported previously in Caucasian
individuals [6].
Statistical analysis
Data analysis was performed using the SPSS software ver-
sion 17.0. To assess the degree of association between
methylation levels and/or auxological parameters within
twin pairs and between groups, we used Pearson correla-
tion coefficients. Inter-twin-pair differences were analyzed
using Student’s t-tests, intra-twin-pair differences using a
paired t-test. Backward stepwise multivariate linear regres-
sion analysis was performed to identify the independent
variables that best predicted methylation levels.
Testing for differences in the degree of methylation
between genotypes was performed using one-way ANO-
VAs and t-tests. Since both methods assume that all
observations are independent, which for methylation
values of MZ twins might not be the case, we re-calculated
the differences between the genotype groups regarding
COMT methylation in blood and saliva using a mixed lin-
ear model with methylation and genotype as two fixed fac-
tors and with family as a random factor to account for
within-family dependence. In addition, under the assump-
tion of an additive mode of inheritance we tested an addi-
tive genetic model (1df test) using linear regression
analysis by coding genotype information as 0, 1, or 2
copies of the minor allele for each SNP, respectively.
A p-value < 0.05 was considered statistically signifi-
cant; a p-value between 0.05 and 0.1 as an indicator for
a statistical trend of significance.
Results
Among the twin samples, we observed a high variability of
individual methylation levels at both analyzed CG sites. In
blood derived DNA, levels ranged from 26.5 to 48.3%
(mean 40.1 ± 5.4%) at CG1 (CG 23 in reference 14) and
from 48.7 to 70.1% (mean 61.9 ± 6.1%) at CG2 (CG 27 in
reference 14). In saliva DNA, levels ranged from 13.9 to
51.3% (mean 30.2 ± 8.2%) at CG1 and from 21.0 to 68.0%
(mean 41.8 ± 10.6%) at CG2. In both specimens there was
a strong correlation between methylation levels at these
two CG dinucleotides (CG1 vs. CG2: R = 0.94, p < 0.001
for saliva DNA; R = 0.95, p < 0.001 for blood DNA). This
is in accordance with the findings of Mill et al. [15], who
also reported on a relatively high correlation coefficient
(R = 0.77) of methylation levels at these two CG sites in
saliva derived DNA. In addition, we found a significant
intra-individual correlation between blood vs. saliva DNA
methylation levels (R = 0.386, p = 0.024; Figure 3).
Finally, we observed a remarkable intra-twin pair corre-
lation of mean S-COMT methylation levels (donor vs.
recipient: R = 0.77, p < 0.001 in blood DNA and R = 0.41,
p = 0.106 in saliva DNA; the latter coefficient increased to
R = 0.80, p < 0.001 after exclusion of one pair with an
exceptionally high intra-pair variation; see Figure 4). These
findings led us to assume a strong heritability of individual
S-COMT promoter methylation levels.
S-COMT promoter methylation and genetic background
We determined genotypes for the variants rs6269-A/G,
rs4633-C/T, and rs4680-A/G for all twin pairs and com-
pared S-COMT promoter methylation levels among the
genotype groups. In blood derived DNA, we found highly
significant associations of methylation levels with each of
the analyzed genotypes (table 1). Testing for differences
was performed using one-way ANOVAs and t-tests. Since
both methods assume that all observations are indepen-
dent, which for methylation values of MZ twins might not
be the case, we re-calculated the differences between the
genotype groups regarding COMT methylation in blood
and saliva using a mixed linear model. This did not change
the observed significance levels for methylation differences
between the respective genotypes in blood samples. In sal-
iva DNA, variation of methylation for both analysed CGs
was markedly higher, and mean methylation levels
Figure 3 Intra-individual correlation between saliva and blood
DNA methylation levels at the S-COMT promoter (mean
methylation = (CG1 + CG2)/2)).
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nificance (table 2) when distinguishing between two geno-
type groups; the analysis between all three groups using
the mixed linear model did not reveal significant differ-
ences. In addition, under the assumption of an additive
mode of inheritance we tested an additive genetic model,
which confirmed the significance levels between genotype
groups for blood DNA in both cohorts (table 1/3) and
revealed trends for the saliva samples (rs6269: p = 0.086;
rs4633: p = 0.070; rs4680: p = 0.070).
Because any additional sequence variation would have
to be considered as a potential source of amplification
bias in the SNuPE analysis, we excluded the presence of
additional SNPs by direct genomic sequencing in all 20
twin pairs. We did not detect any further sequence
variation.
Next, we analyzed S-COMT promoter methylation and
COMT genotypes in an additional sample of 93 healthy
adult blood donors. Methylation levels at both cytosines
(lymphocyte DNA only; CG1 mean 42,2 ± 5,9%; CG2
mean 55,9 ± 5,7%), range of variation, as well as genotype-
epigenotype associations (all p < 0.01) were comparable to
those seen in the twin cohort. We did not detect any sig-
nificant changes in the methylation pattern that may be
related to the considerable age difference between the two
cohorts.
Considering the functional relevance of three major
COMT haplotypes due to variation in the mRNA second-
ary structure and differences in protein expression, we
were interested to see whether promoter methylation
levels parallel the proposed phenotypical grading into low-
(LPS), average- (APS), and high-pain-sensitive (HPS),
respectively [5,6]. Figure 5 shows mean S-COMT promo-
ter methylation levels with regard to the assumed haplo-
types and displays the putative association in a graphical
way. Belonging to both the high- and the low-pain-sensi-
tive haplotype, rs4680 mutant alleles (158Val) were found
at both ends of the epigenotypical range.
Pre-and postnatal growth, COMT-genotypes and S-COMT
promoter methylation
In order to determine a potential impact of environmental
factors on the individual S-COMT promoter methylation,
we compared methylation levels with pre- and postnatal
growth parameters. Concerning the FFTS-status, we did
not detect differences in methylation levels between
donors and recipients (see table 4), even when analyzing
only the subgroup of twin pairs with discordant birth
weight (10 pairs with a difference of > 10%, data not
shown).
We next aimed to directly correlate auxological para-
meters with methylation levels. Disregarding the informa-
tion on the strong heritability of this locus’ methylation
pattern, we observed a significant correlation between S-
COMT promoter methylation levels and the timing of
laser treatment (r = 0.448; p = 0.006), but no significant
correlations regarding methylation levels vs. gestational
age or auxological birth parameters (birth weight, length,
head circumference). However, COMT genotypes were
not equally distributed among gestational ages at the time
of laser treatment (table 5) as well as at birth (table 6).
After correction for background genetics using linear
regression analysis, only genotype (b = -9.5; p < 0.001) but
not timing of laser treatment or gestational age at birth
contributed significantly to the observed variance of
COMT methylation.
At birth intra-twin-pair differences were greater than 1.0
SDS in 10/19 for birth length (data missing in one pair)
and greater than 10% in 10/20 pairs for birth weight,
respectively. After 4 years only 4 twin pairs were still dis-
cordant in length-SDS. We compared both the delta-SD
scores (height) in intra-twin-pair approximation and indi-
vidual height within the total sample of 40 children with
measurements of absolute and delta S-COMT methyla-
tion. Both with and without correction for genotypes, we
Figure 4 Intra-twinpair correlation between both twins for
blood- (A) and saliva-derived DNA (B). Note that in (B) one pair
of outliers was not included in the analysis.
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Page 5 of 12Table 1 S-COMT methylation [% ± SD] with respect to COMT genotype in Blood DNA (twin cohort)
Variant CG1 CG2b mean CG1 CG2b mean CG1 CG2b mean p-value
rs6269 AA 44.8 ± 3.1 67.1 ± 3.1 56.0 ± 3.0 (n = 10) AG 40.3 ± 3.0 62.1 ± 3.9 51.2 ± 3.4 (n = 24) GG 30.6 ± 3.0 51.4 ± 3.0 41.0 ± 2.7 (n = 6) < 0.01
rs4633 CC 33.2 ± 5.3 54.2 ± 5.8 43.7 ± 5.4 (n = 8) CT 40.3 ± 3.2 62.0 ± 4.1 51.2 ± 3.5 (n = 22) TT 44.8 ± 3.1 67.1 ± 3.1 56.0 ± 3.0 (n = 10) < 0.01
rs4680 AA 44.8 ± 3.1 67.1 ± 3.1 56.0 ± 3.0 (n = 10) AG 40.3 ± 3.2 62.0 ± 4.1 51.2 ± 3.5 (n = 22) GG 33.2 ± 5.3 54.2 ± 5.8 43.7 ± 5.4 (n = 8) < 0.01
Note that similar or equal methylation values across genotype groups for different SNPs result from a high (in the twin cohort almost complete) linkage disequilibrium between rs6269, rs4633, and rs4680. Please
note that shown p-values were calculated using one-way ANOVAs, which do not take the interrelatedness of the observations into account.
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2Table 2 S-COMT methylation [% ± SD] with respect to COMT genotypes in Saliva DNA (twin cohort)
Variant CG1 CG2b mean CG1 CG2b mean CG1 CG2b mean p-value
rs6269 AA 34.7 ± 14.7 43.4 ± 18.0 39.0 ± 16.2 (n = 10) AG 30.9 ± 6.1 40.5 ± 7.8 35.7 ± 6.8 (n = 24) GG 23.1 ± 9.3 31.9 ± 11.9 27.5 ± 10.6 (n = 6) < 0.05 *
rs4633 CC 24.7 ± 8.2 33.2 ± 10.1 28.9 ± 9.1 (n = 8) CT 31.2 ± 6.2 41.0 ± 7.8 36.1 ± 6.8 (n = 22) TT 34.7 ± 14.7 43.4 ± 18.0 39.0 ± 16.2 (n = 10) < 0.05 *
rs4680 AA 34.7 ± 14.7 43.4 ± 18.0 39.0 ± 16.2 (n = 10) AG 31.2 ± 6.2 41.0 ± 7.8 36.1 ± 6.8 (n = 22) GG 24.7 ± 8.2 33.2 ± 10.1 28.9 ± 9.1 (n = 8) < 0.05 *
* rs6269: AG vs. GG p < 0.05; rs4633: CC vs. CT p < 0.05; rs4680: AG vs. GG p < 0.05. Please note that shown p-values were calculated using t-tests, which does not take the interrelatedness of the observations into
account.
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2did not see any significant association between postnatal
growth parameters and methylation levels (p > 0.05 in all
analyses). As mentioned above, two children suffered from
intracranial bleeding und a subsequent delay in motor-
development. Postnatal growth of these two children was
obviously impaired, whereas S-COMT promoter methyla-
tion appeared to be unaffected by this condition as it was
well within the intra-twin-pair range seen in the remaining
pairs.
Finally, we detected a tendency towards slightly higher
methylation levels in males (mean S-COMT promoter
methylation 48.5 +/- 5.8% in females versus 53.0 +/-
4.8% in males; p = 0.01). Similar differences have been
reported previously for other non-imprinted loci [27].
Inclusion of gender in linear regression analysis did not
affect genotype-epigenotype associations in twins. In
blood donors, inclusion of gender in the linear regres-
sion analysis led to an increase of R
2 from 0.534 to
0.609, explaining an additional 7.5% of variance. There-
fore we assume that the overall confounding effect of
gender is small compared to the association with
COMT genotypes.
Discussion
Based on two studies reporting on partial methylation of
two CG sites within the S-COMT promoter region
[14,15], we aimed to determine whether and to which
extent environmental and genetic variables associate
with the individual epigenetic profile at the S-COMT
promoter in a cohort of discordant monozygotic twins.
Our findings provide evidence for a strong interaction
between genetic background and S-COMT promoter
methylation. Considering the well recognized functional
relevance of discrete genomic variation and the physio-
logical role of locus-specific cytosine methylation in the
context of transcription and gene expression, such an
association is not surprising. Indeed, there are several
recent reports on locus-specific methylation patterns
that are closely associated with the genetic background
[28-33]. Moreover, we did not detect any significant
association between methylation levels and pre- or post-
natal growth parameters and could confirm the close
relation between genotype and epigenotype in a separate
cohort of adult singleton blood donors. Interestingly,
methylation levels in 4-year-old children and adults
were largely comparable, which further underlines the
close relation between genetic background and promo-
ter methylation at this locus.
While planning this study we were aware that methy-
lation analyses using peripheral blood derived DNA in
monozygotic twins may be biased due to their fused cir-
culations. Fetal sharing of circulating blood has been
described in monozygotic twin pregnancies even without
the presence of FFTS [34]. In a study on monocygotic
twins discordant for Beckwith-Wiedemann syndrome,
Weksberg et al. reported on imprinting abnormalities in
hematopoietic cells from both the affected and the unaf-
fected twin, whereas in fibroblasts epigenetic defects
were found in the affected twin only [35]. Thus we
decided to analyze DNA from two tissues: blood and
oral epithelial cell samples. Preceding laboratory tests
using conventional buccal smears revealed a high degree
Figure 5 Mean S-COMT methylation levels with respect to the presumed COMT haplotype carrier status (A = twin cohort, B = adult
controls). In both cohorts, no individuals homozygous for the HPS haplotype were found. All other haplotype combinations were ranked within
an imaginary scale corresponding to the proposed phenotypical differences (high > average > low pain sensitive, according to [Nackley et al.,
2006]).
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Page 8 of 12Table 3 S-COMT methylation [% ± SD] with respect to COMT genotype in Blood DNA (blood donors)
Variant CG1 CG2b mean CG1 CG2b mean CG1 CG2b mean p-value
rs6269 AA 47.0 ± 4.6 60.1 ± 3.7 53.6 ± 3.5 (n = 26) AG 42.2 ± 4.7 55.7 ± 5.1 49.0 ± 4.8 (n = 44) GG 36.6 ± 4.6 51.4 ± 5.3 44.0 ± 4.8 (n = 23) < 0.01
rs4680 AA 47.3 ± 4.2 60.3 ± 3.7 53.8 ± 3.4 (n = 33) AG 40.8 ± 3.8 54.7 ± 4.5 47.8 ± 4.0 (n = 46) GG 34.1 ± 4.1 49.1 ± 5.4 41.6 ± 4.5 (n = 14) < 0.01
Note that due to the high linkage disequilibrium between rs6269, rs4633, and rs4680, in the replication cohort we assessed only rs6269 and rs4680, which are sufficient to differentiate between the 3 common
activity haplotypes.
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2of variation regarding both amount and purity of DNA,
which may result from bacterial contamination and/or
DNA degradation even during short term storage of
these specimens. Accordingly, methylation measure-
ments in smears taken from the same individual at the
same time were scarcely reproducible (data not shown).
In contrast, methylation measurements using DNA from
Oragene liquid saliva samples revealed a markedly
higher intra-individual reproducibility. This may explain
why Mill et al. who exclusively analyzed S-COMT
methylation in buccal smear DNA failed to detect a
similar heritability in their twin cohort [15]. On the
other hand, this group had selected their twins primarily
o nt h ep r e s e n c eo fas i g n i f i c ant discordance in birth
weight. Although they do not give detailed information
on the underlying pathology, we speculate that the
majority of these twin pairs suffered from conditions
that worsened in the last trimester of pregnancy, in con-
trast to an equalization of the formerly disproportionate
(mid-trimester) blood supply in our FFTS twins. Thus,
differences in the plasticity of the (S-COMT promoter)
epigenetic encoding during different periods of the
intrauterine development might explain this discrepancy,
too.
We were not able to detect significant differences in
S-COMT promoter methylation levels between donors
and recipients. This seems to indicate that the adverse
intrauterine environment due to FFTS until decompen-
sation and laser treatment did not influence formation
and/or maintenance of the promoter methylation at this
region. Within the period after laser treatment however
auxological parameters converged in the majority of
twin pairs, meaning that critical differences in placental
supply had been dissolved. Consequently, a potential
impact of malnutrition during later gestational phases
may be missed by our approach.
In order to eliminate any amplification bias that may arise
from the occurrence of single nucleotide polymorphisms
within or nearby the primer regions, we sequenced the S-
COMT promoter region in genomic DNA samples from all
20 twin pairs and did not detect any new sequence varia-
tion. Another potential source of biased methylation analy-
sis however remains the lack of information on the
leukocyte subtype distribution in the blood samples used
for DNA extraction. This issue has already been discussed
by Boks et al. in their recent publication on methylation
levels of several CG loci found to be closely linked to
genetic polymorphisms in a large-scale twin study using the
Illumina GoldenGate assay [33]. Although we do not have
current leukocyte subtype counts, the conserved (albeit less
clear) genotype-epigenotype-association found in the Ora-
gene saliva samples seems to rule out this objection.
A limitation of our study is that we do not have quanti-
tative mRNA measurements, which would allow us to
evaluate our findings with respect to the physiological
entity of promoter methylation and transcriptional activity.
In vitro experiments by Nackley and co-workers using
transfected full-length COMT cDNA that differed only in
three nucleotides within the coding region of exons 1 and
2 revealed marked differences in the levels of protein
expression and enzyme activity which could be explained
by either differences in mRNA secondary structure stabi-
lity or, to less extent, a previously reported decrease in
protein thermostability mediated by the 158Met allele.
Total COMT RNA abundance, in contrast, did not parallel
COMT protein levels, most likely attributing to the nature
of their experimental design in that COMT was expressed
in vitro under the regulation of identical promoters [6].
Our data provide evidence that a set of polymorphisms
within the promoter and coding region of this gene
strongly associates with the methylation status of the
(S-COMT-) promoter region. Interestingly, individuals
assumed to carry two alleles with the LPS haplotype, which
was previously associated with the relatively highest S-
COMT enzyme activity (figure one in ref. [6]), exhibited a
markedly lower S-COMT promoter methylation as com-
pared to those carrying the APS and HPS alleles (Figure 5).
Presuming an inverse relation between promoter methyla-
tion and transcriptional activity, a constellation of lower
promoter methylation in alleles associated previously with
higher protein activity and vice versa would conflict with
the assumption of a simple feed-back response between
transcriptional activity and the abundance of either COMT
Table 4 Auxiological and epigenetic differences between
donors and recipients (mean ± SEM)
Donors Recipients p-value
Birth weight SDS -1.45 ± 0.2 -0.64 ± 0.2 < 0.01
Birth length SDS -1.6 ± 0.3 -0.5 ± 0.2 < 0.01
Height SDS (follow-up) -0.8 ± 0.2 -0.3 ± 0.2 < 0.01
BMI SDS (follow-up) -0.7 ± 0.2 -0.1 ± 0.2 < 0.01
S-COMT methylation (blood) 50.4 ± 1.4 51.6 ± 1.2 n.s.
S-COMT methylation (saliva) 36.5 ± 2.1 35.0 ± 2.2 n.s.
Table 5 Genotype and gestational age at laser treatment (mean ± SD)
Wks wks wks p-value
rs6269 AA 22.4 ± 1.2 (n = 10) AG 20.5 ± 2.4 (n = 24) GG 18.8 ± 0.5 (n = 6) < 0.01
rs4633 CC 18.8 ± 0.4 (n = 8) CT 20.7 ± 2.5 (n = 22) TT 22.4 ± 1.2 (n = 10) < 0.01
rs4680 AA 22.4 ± 1.2 (n = 10) AG 20.7 ± 2.5 (n = 22) GG 18.8 ± 0.4 (n = 8) < 0.01
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Page 10 of 12protein or its substrates. Indeed, besides an estrogenic
down-regulation of COMT expression mediated by estro-
gen response elements that have been found in the promo-
ter regions of both the proximal S-COMT and the distal
MB-COMT promoter [36,37], there is also evidence for an
induction of COMT by estradiol and ethinyl-estradiol
which would be consistent with the assumption of a phy-
siological response to a threat to the genome by catechol-
estrogens that can be blocked by their O-methylation
[36,38].
To our knowledge, the only comprehensive investigation
so far that aimed to analyze COMT epigenotype, geno-
type, and phenotype including mRNA expression data is
the study of Abdolmaleky et al. [13]. The authors report
on MB-COMT promoter hypomethylation with a conco-
mitant increase in MB-COMT transcription in frontal
lobe tissue from schizophrenia and bipolar disorder
patients, as compared to unaffected controls. Except for a
borderline significance found for the enrichment of
158Val alleles with MB-COMT promoter hypomethyla-
tion and disease disposition, there was however no consis-
tent relation between individual epigenotype and the
Val158Met polymorphism. It will be interesting to test
whether the inclusion of further genetic variants may
strengthen the relation between genotype and epigenotype
as seen for the S-COMT promoter methylation in lym-
phocytes in our sample.
Conclusion
Our data revealed a strong heritable component of indi-
vidual S-COMT promoter methylation. Simultaneous
consideration of heritable, i.e. genetic components
should be a basic item in all studies that focus on the
relation between phenotype and epigenotype.
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